[시장보고서]세계의 중간엽 줄기세포 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 제품 및 서비스별, 워크플로우별, 유형별, 분리원별, 적응증별, 용도별, 지역별 경쟁(2020-2030년)

세계의 중간엽 줄기세포 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 제품 및 서비스별, 워크플로우별, 유형별, 분리원별, 적응증별, 용도별, 지역별 경쟁(2020-2030년)

Mesenchymal Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Workflow, By Type, By Source of Isolation, By Indication, By Application, By Region & Competition, 2020-2030F

상품코드 : 1738267

리서치사 : TechSci Research

발행일 : 2025년 05월

페이지 정보 : 영문 182 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,531,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,982,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,611,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 중간엽 줄기세포 시장은 2024년에는 27억 1,000만 달러로 평가되었으며, 2030년까지 연평균 복합 성장률(CAGR) 8.54%를 나타낼 것으로 예측됩니다.

이 시장은 재생의료에 있어서의 급속한 진보, 임상시험활동의 활성화, 중간엽 줄기세포(MSCs)의 치료가능성에 대한 의식이 높아짐에 따라 견인력을 늘리고 있습니다. 정형외과, 신경학, 심장병, 자가면역질환에의 응용에 적합합니다.

시장 개요
예측 기간	2026-2030
시장 규모 : 2024년	27억 1,000만 달러
시장 규모 : 2030년	44억 달러
CAGR : 2025-2030년	8.54%
급성장 부문	동종
최대 시장	북미

시장 성장 촉진요인

만성 질환 증가

주요 시장 과제

규제 문제

주요 시장 동향

기술 진보

시장 규모 및 예측
- 금액별
시장 점유율 및 예측
- 제품 및 서비스별 {제품(세포 및 세포주, 키트, 배지, 시약 등), 서비스}
- 워크플로우별(세포 소싱 및 분리, 배양 및 동결보존, 분화, 특성화)
- 유형별(자가이식, 동종이식)
- 분리원별(골수, 제대혈, 말초혈, 나팔관, 태아 간, 폐, 지방조직)
- 적응증별(뼈 및 연골 복구, 심혈관 질환, 염증 및 면역 질환, 간 질환, 암, GVHD, 기타)
- 용도별(질환 모델링, 의약품 개발 및 발견, 줄기세포 은행, 조직 공학, 독성학 연구, 기타)
- 지역별
- 기업별(2024년)
시장 맵

제6장 북미의 중간엽 줄기세포 시장 전망

시장 규모 및 예측
시장 점유율 및 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 중간엽 줄기세포 시장 전망

시장 규모 및 예측
시장 점유율 및 예측
유럽 : 국가별 분석
- 독일
- 영국
- 이탈리아
- 프랑스
- 스페인

제8장 아시아태평양의 중간엽 줄기세포 시장 전망

시장 규모 및 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 남미의 중간엽 줄기세포 시장 전망

시장 규모 및 예측
시장 점유율 및 예측
남미 : 국가별 분석
- 브라질
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카의 중간엽 줄기세포 시장 전망

시장 규모 및 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

합병과 인수
제품 개발
최근 동향

제13장 세계의 중간엽 줄기세포 시장 : SWOT 분석

제14장 경쟁 구도

Thermo Fisher Scientific, Inc
Cell Applications, Inc
Axol Biosciences Ltd
Cytori Therapeutics Inc
STEMCELL Technologies
Cyagen Biosciences
Celprogen Inc
BrainStorm Cell Limited
Stemedica Cell Technologies Inc
Merck KGaA(MilliporeSigma)
PromoCell GmbH

제15장 전략적 제안

제16장 기업 소개와 면책사항

KTH

영문 목차

영문목차

The Global Mesenchymal Stem Cells (MSCs) Market was valued at USD 2.71 billion in 2024 and is projected to grow at a CAGR of 8.54% through 2030. This market is gaining traction due to rapid advancements in regenerative medicine, increased clinical trial activity, and rising awareness of the therapeutic potential of MSCs. Known for their ability to differentiate into various cell types such as bone, cartilage, and adipose tissues, MSCs have shown promise in treating a wide range of medical conditions. Their immunomodulatory and anti-inflammatory properties, combined with low immunogenicity, make them suitable for applications in orthopedics, neurology, cardiology, and autoimmune diseases. Increasing research investments and favorable demographic trends, including an aging population with rising incidences of chronic conditions, are further propelling the market. The scope of MSC applications continues to broaden, encompassing emerging areas such as dermatology and oncology, while technological innovations and expanding clinical studies underline the potential for MSCs in both therapeutic and research domains.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.71 Billion
Market Size 2030	USD 4.40 Billion
CAGR 2025-2030	8.54%
Fastest Growing Segment	Allogenic
Largest Market	North America

Key Market Drivers

Rising Prevalence of Chronic Diseases

The growing burden of chronic illnesses such as diabetes, cardiovascular diseases, neurodegenerative conditions, and arthritis is significantly driving demand for mesenchymal stem cell-based therapies. As these long-term diseases impose substantial health and economic burdens globally, MSCs offer a regenerative and immunomodulatory approach that addresses underlying tissue damage and inflammation. Their application in chronic disease management is supported by increasing interest in cell-based therapies that promote healing and reduce dependency on symptomatic treatments. The World Health Organization attributes approximately 71% of global deaths to chronic diseases, underscoring the urgent need for innovative therapies like MSCs, which are becoming integral to modern medical approaches.

Key Market Challenges

Regulatory Challenges

Navigating the regulatory environment presents a key challenge for the MSC market. Regulations vary significantly across regions, affecting the approval, manufacturing, and commercialization of MSC-based products. Adhering to Good Manufacturing Practices (GMP) and gaining regulatory approvals can be time-consuming and financially burdensome. The lack of globally harmonized standards also complicates market entry for developers and manufacturers. As the demand for MSC therapies rises, the development of streamlined and unified regulatory pathways will be critical to facilitating wider access and accelerating growth in the global market.

Key Market Trends

Technological Advancements

Technological innovations are transforming the MSC landscape, enabling more efficient and scalable production, enhanced therapeutic efficacy, and targeted delivery. Advances in bioreactor technology, 3D scaffolds, and microfluidic systems have improved the reproducibility and yield of MSC cultures. Tools like CRISPR-Cas9 are being used to genetically modify MSCs to enhance regenerative or immunological capabilities. Progress in biomaterials and drug delivery platforms allows for precise MSC deployment, improving clinical outcomes. Automation and robotic systems are streamlining MSC manufacturing, while imaging techniques like MRI and bioluminescent imaging provide real-time tracking of therapeutic cells. These advancements collectively support the expansion of MSC-based applications and ensure consistency in product quality, aiding in broader adoption across healthcare systems.

Key Market Players

Thermo Fisher Scientific, Inc
Cell Applications, Inc
Axol Biosciences Ltd
Cytori Therapeutics Inc
STEMCELL Technologies
Cyagen Biosciences
Celprogen Inc
BrainStorm Cell Limited
Stemedica Cell Technologies Inc
Merck KGaA (MilliporeSigma)
PromoCell GmbH

Report Scope:

In this report, the Global Mesenchymal Stem Cells Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mesenchymal Stem Cells Market, By Product & Services:

Product
Services

Mesenchymal Stem Cells Market, By Workflow:

Cell Sourcing & Isolation
Culture & Cryopreservation
Differentiation
Characterization

Mesenchymal Stem Cells Market, By Type:

Autologous
Allogeneic

Mesenchymal Stem Cells Market, By Source of Isolation:

Bone Marrow
Cord Blood
Peripheral Blood
Fallopian Tube
Fetal Liver
Lung
Adipose Tissues

Mesenchymal Stem Cells Market, By Indication:

Bone And Cartilage Repair
Cardiovascular Disease
Inflammatory And Immunological Diseases
Liver Diseases
Cancer
GvHD
Others

Mesenchymal Stem Cells Market, By Application:

Disease Modelling
Drug Development & Discovery
Stem Cell Banking
Tissue Engineering
Toxicology Studies
Others

Mesenchymal Stem Cells Market, By Region:

North America
Europe
Asia-Pacific
South America
Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mesenchymal Stem Cells Market.

Available Customizations:

Global Mesenchymal Stem Cells market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Mesenchymal Stem Cells Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product & Services {Products (Cells & Cell Lines, Kits, Media, & Reagents, Others), Services}
- 5.2.2. By Workflow (Cell Sourcing & Isolation, Culture & Cryopreservation, Differentiation, Characterization)
- 5.2.3. By Type (Autologous, Allogeneic)
- 5.2.4. By Source of Isolation (Bone Marrow, Cord Blood, Peripheral Blood, Fallopian Tube, Fetal Liver, Lung, Adipose Tissues)
- 5.2.5. By Indication (Bone and Cartilage Repair, Cardiovascular Disease, Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD, Others)
- 5.2.6. By Application (Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Others)
- 5.2.7. By Region
- 5.2.8. By Company (2024)
5.3. Market Map

6. North America Mesenchymal Stem Cells Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product & Services
- 6.2.2. By Workflow
- 6.2.3. By Type
- 6.2.4. By Source of Isolation
- 6.2.5. By Indication
- 6.2.6. By Application
- 6.2.7. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Mesenchymal Stem Cells Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product & Services
    - 6.3.1.2.2. By Workflow
    - 6.3.1.2.3. By Type
    - 6.3.1.2.4. By Source of Isolation
    - 6.3.1.2.5. By Indication
    - 6.3.1.2.6. By Application
- 6.3.2. Canada Mesenchymal Stem Cells Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product & Services
    - 6.3.2.2.2. By Workflow
    - 6.3.2.2.3. By Type
    - 6.3.2.2.4. By Source of Isolation
    - 6.3.2.2.5. By Indication
    - 6.3.2.2.6. By Application
- 6.3.3. Mexico Mesenchymal Stem Cells Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product & Services
    - 6.3.3.2.2. By Workflow
    - 6.3.3.2.3. By Type
    - 6.3.3.2.4. By Source of Isolation
    - 6.3.3.2.5. By Indication
    - 6.3.3.2.6. By Application

7. Europe Mesenchymal Stem Cells Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product & Services
- 7.2.2. By Workflow
- 7.2.3. By Type
- 7.2.4. By Source of Isolation
- 7.2.5. By Indication
- 7.2.6. By Application
- 7.2.7. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Mesenchymal Stem Cells Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product & Services
    - 7.3.1.2.2. By Workflow
    - 7.3.1.2.3. By Type
    - 7.3.1.2.4. By Source of Isolation
    - 7.3.1.2.5. By Indication
    - 7.3.1.2.6. By Application
- 7.3.2. United Kingdom Mesenchymal Stem Cells Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product & Services
    - 7.3.2.2.2. By Workflow
    - 7.3.2.2.3. By Type
    - 7.3.2.2.4. By Source of Isolation
    - 7.3.2.2.5. By Indication
    - 7.3.2.2.6. By Application
- 7.3.3. Italy Mesenchymal Stem Cells Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Product & Services
    - 7.3.3.2.2. By Workflow
    - 7.3.3.2.3. By Type
    - 7.3.3.2.4. By Source of Isolation
    - 7.3.3.2.5. By Indication
    - 7.3.3.2.6. By Application
- 7.3.4. France Mesenchymal Stem Cells Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product & Services
    - 7.3.4.2.2. By Workflow
    - 7.3.4.2.3. By Type
    - 7.3.4.2.4. By Source of Isolation
    - 7.3.4.2.5. By Indication
    - 7.3.4.2.6. By Application
- 7.3.5. Spain Mesenchymal Stem Cells Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product & Services
    - 7.3.5.2.2. By Workflow
    - 7.3.5.2.3. By Type
    - 7.3.5.2.4. By Source of Isolation
    - 7.3.5.2.5. By Indication
    - 7.3.5.2.6. By Application

8. Asia-Pacific Mesenchymal Stem Cells Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product & Services
- 8.2.2. By Workflow
- 8.2.3. By Type
- 8.2.4. By Source of Isolation
- 8.2.5. By Indication
- 8.2.6. By Application
- 8.2.7. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Mesenchymal Stem Cells Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product & Services
    - 8.3.1.2.2. By Workflow
    - 8.3.1.2.3. By Type
    - 8.3.1.2.4. By Source of Isolation
    - 8.3.1.2.5. By Indication
    - 8.3.1.2.6. By Application
- 8.3.2. India Mesenchymal Stem Cells Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product & Services
    - 8.3.2.2.2. By Workflow
    - 8.3.2.2.3. By Type
    - 8.3.2.2.4. By Source of Isolation
    - 8.3.2.2.5. By Indication
    - 8.3.2.2.6. By Application
- 8.3.3. Japan Mesenchymal Stem Cells Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product & Services
    - 8.3.3.2.2. By Workflow
    - 8.3.3.2.3. By Type
    - 8.3.3.2.4. By Source of Isolation
    - 8.3.3.2.5. By Indication
    - 8.3.3.2.6. By Application
- 8.3.4. South Korea Mesenchymal Stem Cells Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product & Services
    - 8.3.4.2.2. By Workflow
    - 8.3.4.2.3. By Type
    - 8.3.4.2.4. By Source of Isolation
    - 8.3.4.2.5. By Indication
    - 8.3.4.2.6. By Application
- 8.3.5. Australia Mesenchymal Stem Cells Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product & Services
    - 8.3.5.2.2. By Workflow
    - 8.3.5.2.3. By Type
    - 8.3.5.2.4. By Source of Isolation
    - 8.3.5.2.5. By Indication
    - 8.3.5.2.6. By Application

9. South America Mesenchymal Stem Cells Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product & Services
- 9.2.2. By Workflow
- 9.2.3. By Type
- 9.2.4. By Source of Isolation
- 9.2.5. By Indication
- 9.2.6. By Application
- 9.2.7. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Mesenchymal Stem Cells Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product & Services
    - 9.3.1.2.2. By Workflow
    - 9.3.1.2.3. By Type
    - 9.3.1.2.4. By Source of Isolation
    - 9.3.1.2.5. By Indication
    - 9.3.1.2.6. By Application
- 9.3.2. Argentina Mesenchymal Stem Cells Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product & Services
    - 9.3.2.2.2. By Workflow
    - 9.3.2.2.3. By Type
    - 9.3.2.2.4. By Source of Isolation
    - 9.3.2.2.5. By Indication
    - 9.3.2.2.6. By Application
- 9.3.3. Colombia Mesenchymal Stem Cells Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product & Services
    - 9.3.3.2.2. By Workflow
    - 9.3.3.2.3. By Type
    - 9.3.3.2.4. By Source of Isolation
    - 9.3.3.2.5. By Indication
    - 9.3.3.2.6. By Application

10. Middle East and Africa Mesenchymal Stem Cells Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product & Services
- 10.2.2. By Workflow
- 10.2.3. By Type
- 10.2.4. By Source of Isolation
- 10.2.5. By Indication
- 10.2.6. By Application
- 10.2.7. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Mesenchymal Stem Cells Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product & Services
    - 10.3.1.2.2. By Workflow
    - 10.3.1.2.3. By Type
    - 10.3.1.2.4. By Source of Isolation
    - 10.3.1.2.5. By Indication
    - 10.3.1.2.6. By Application
- 10.3.2. Saudi Arabia Mesenchymal Stem Cells Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product & Services
    - 10.3.2.2.2. By Workflow
    - 10.3.2.2.3. By Type
    - 10.3.2.2.4. By Source of Isolation
    - 10.3.2.2.5. By Indication
    - 10.3.2.2.6. By Application
- 10.3.3. UAE Mesenchymal Stem Cells Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product & Services
    - 10.3.3.2.2. By Workflow
    - 10.3.3.2.3. By Type
    - 10.3.3.2.4. By Source of Isolation
    - 10.3.3.2.5. By Indication
    - 10.3.3.2.6. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition
12.2. Product Development
12.3. Recent Developments

13. Global Mesenchymal Stem Cells Market: SWOT Analysis

14. Competitive Landscape

14.1. Thermo Fisher Scientific, Inc
- 14.1.1. Business Overview
- 14.1.2. Age Group Offerings
- 14.1.3. Recent Developments
- 14.1.4. Key Personnel
- 14.1.5. SWOT Analysis
14.2. Cell Applications, Inc
14.3. Axol Biosciences Ltd
14.4. Cytori Therapeutics Inc
14.5. STEMCELL Technologies
14.6. Cyagen Biosciences
14.7. Celprogen Inc
14.8. BrainStorm Cell Limited
14.9. Stemedica Cell Technologies Inc
14.10. Merck KGaA (MilliporeSigma)
14.11. PromoCell GmbH